“Media studies describe it as a loophole,” states Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s extremely intentional policy.” Brunner has expressed frustration regarding how some coverage in the increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medications or research peptides with credentialed functions https://johns555mpo7.shoutmyblog.com/profile